<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Medical Devices Industry: Market Research Reports, Statistics and Analysis]]></title>
    <link>http://www.reportlinker.com/ci02249/Medical-Devices.html</link>
    <description><![CDATA[Reportlinker.com Lastest Medical Devices Industry: Market Research Reports, Statistics and Analysis]]></description>
    <pubDate>Mon, 21 May 2012 16:07:03 +0000</pubDate>
    <webMaster>support@reportlinker.com</webMaster>
    <copyright>Copyright 2012, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[U.S. Pathology Laboratory Industry]]></title>
      <link>http://www.reportlinker.com/d013039777/U-S-Pathology-Laboratory-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013039777/U-S-Pathology-Laboratory-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... To  In-sourced  Specialty practices  decreased attractiveness of pathology to graduating medical students:      - <strong>pathology</strong> & <strong>laboratory</strong> medicine as a  Commodity       - Anatomic pathology as an in ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Orthopedic in The United States for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013048575/Company-Report-Orthopedic-in-The-United-States-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013048575/Company-Report-Orthopedic-in-The-United-States-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Of  solutions exclusively targeted toward <strong>orthopedic</strong> specialty providers that enables these types of practices  to leverage technology to enhance the efficiency of their practice while improving patient care ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Industry report on Computed Tomography and Nuclear Imaging Equipment in The United States]]></title>
      <link>http://www.reportlinker.com/d013055705/Industry-report-on-Computed-Tomography-and-Nuclear-Imaging-Equipment-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013055705/Industry-report-on-Computed-Tomography-and-Nuclear-Imaging-Equipment-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/screenshots/13055705_sm.jpg" width="80px" height="65px"> ... Of a major <strong>cardiac</strong> <strong>pet</strong> radiopharmaceutical, rubidium, are   expected to grow from $70 million to over $200 million in 2015.  //  The annual demand for higher energy accelerator isotopes used in   medical ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Orthopedic for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013058556/Company-Report-Orthopedic-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013058556/Company-Report-Orthopedic-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Orthotic devices, <strong>orthopedic</strong> <strong>supports</strong> and braces.  The payment rates for orthotic  devices, <strong>orthopedic</strong> <strong>supports</strong> and braces are set forth in 114.3 Cmr 34.00.      (5) Nutritional supplements.  The payment ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Medical Devices in The United States and Europe for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013062598/Company-Report-Medical-Devices-in-The-United-States-and-Europe-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013062598/Company-Report-Medical-Devices-in-The-United-States-and-Europe-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Economic trends.    The us <strong>hearing</strong> <strong>aid</strong> market saw unit growth of 4-5% in the first three months of the year, which is a slight increase on the  historic growth rate. The demand by both the private sector ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Hospital For Sick Children - Company Report for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013063051/Hospital-For-Sick-Children-Company-Report-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013063051/Hospital-For-Sick-Children-Company-Report-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Scept-veterinary tests.  The  mbec assay  Is a high throughput biofilm growth device that was recently approved as an         astm international standard.  Biofilm pa  And innovoscept-human are the first <strong>diagnostic</strong>  <strong>tests</strong> ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Company Report: Medical Devices in The United States for Year 2012]]></title>
      <link>http://www.reportlinker.com/d013063822/Company-Report-Medical-Devices-in-The-United-States-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d013063822/Company-Report-Medical-Devices-in-The-United-States-for-Year-2012.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... New investment transactions   The recapitalization of martex fiber southern corp. ("Martex"), the  recapitalization of innovative <strong>medical</strong> <strong>device</strong> solutions, inc. ("Imds") and acquisition financing for yp ...]]></description>
      <pubDate>Mon, 30 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The 2012 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan<br>Product Development Opportunities and Business Expansion Strategies for Instrumentand Reagent Suppliers]]></title>
      <link>http://www.reportlinker.com/p0365398/The-Clinical-Chemistry-and-Immunodiagnostics-Markets-US-Europe-JapanProduct-Development-Opportunities-and-Business-Expansion-Strategies-for-Instrumentand-Reagent-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0365398/The-Clinical-Chemistry-and-Immunodiagnostics-Markets-US-Europe-JapanProduct-Development-Opportunities-and-Business-Expansion-Strategies-for-Instrumentand-Reagent-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="http://static.reportlinker.com/public/images/pub/1358.gif"> During the next decade, the clinical chemistry and immunodiagnostics markets will undergo significant transformation.  The changes will be caused convergence of new and more stringent regulations; advances ...]]></description>
      <pubDate>Tue, 27 Mar 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[2012 Coagulation Testing Market Outlook: Growth Opportunities and Strategies]]></title>
      <link>http://www.reportlinker.com/p0845315/Coagulation-Testing-Market-Outlook-Growth-Opportunities-and-Strategies.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0845315/Coagulation-Testing-Market-Outlook-Growth-Opportunities-and-Strategies.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="http://static.reportlinker.com/public/images/pub/1358.gif"> The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...]]></description>
      <pubDate>Wed, 18 Apr 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The 2012 Coagulation Testing Market: US, Europe, Japan - Emerging Business Opportunities and Market Expansion Strategies for Suppliers]]></title>
      <link>http://www.reportlinker.com/p0365429/The-Coagulation-Testing-Market-US-Europe-Japan-Emerging-Business-Opportunities-and-Market-Expansion-Strategies-for-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0365429/The-Coagulation-Testing-Market-US-Europe-Japan-Emerging-Business-Opportunities-and-Market-Expansion-Strategies-for-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="http://static.reportlinker.com/public/images/pub/1358.gif"> The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, ...]]></description>
      <pubDate>Tue, 27 Mar 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The 2012 Infectious Disease Testing Market: US, Europe, Japan--Emerging Opportunities and Business Strategies for Suppliers]]></title>
      <link>http://www.reportlinker.com/p0368578/The-Infectious-Disease-Testing-Market-US-Europe-Japan-Emerging-Opportunities-and-Business-Strategies-for-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0368578/The-Infectious-Disease-Testing-Market-US-Europe-Japan-Emerging-Opportunities-and-Business-Strategies-for-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="http://static.reportlinker.com/public/images/pub/1358.gif"> The infectious disease testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers in the 21st century.  Among the main ...]]></description>
      <pubDate>Tue, 27 Mar 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Future Hemostasis Diagnostics Market Outlook: Emerging Opportunities and Business Expansion Strategies]]></title>
      <link>http://www.reportlinker.com/p0787959/Future-Hemostasis-Diagnostics-Market-Outlook-Emerging-Opportunities-and-Business-Expansion-Strategies.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0787959/Future-Hemostasis-Diagnostics-Market-Outlook-Emerging-Opportunities-and-Business-Expansion-Strategies.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="http://static.reportlinker.com/public/images/pub/1358.gif"> Complete report $28,700. &nbsp. This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the ...]]></description>
      <pubDate>Thu, 23 Feb 2012 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The 2012 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers]]></title>
      <link>http://www.reportlinker.com/p0365344/The-Cancer-Diagnostics-Market-US-Europe-Japan-Emerging-Opportunities-and-Business-Expansion-Strategies-for-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0365344/The-Cancer-Diagnostics-Market-US-Europe-Japan-Emerging-Opportunities-and-Business-Expansion-Strategies-for-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="http://static.reportlinker.com/public/images/pub/1358.gif"> The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...]]></description>
      <pubDate>Tue, 27 Mar 2012 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The 2012 Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers]]></title>
      <link>http://www.reportlinker.com/p0368644/The-Molecular-Diagnostics-Market-DNA-Probes-and-Biochips-New-Product-Development-Opportunities-and-Business-Expansion-Strategies-for-Instrument-and-Reagent-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p0368644/The-Molecular-Diagnostics-Market-DNA-Probes-and-Biochips-New-Product-Development-Opportunities-and-Business-Expansion-Strategies-for-Instrument-and-Reagent-Suppliers.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="http://static.reportlinker.com/public/images/pub/1358.gif"> The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry.  The next ten years will witness significant developments in reagent systems and ...]]></description>
      <pubDate>Tue, 27 Mar 2012 22:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>

